title: 5α-reductases in human physiology: an unfolding story.
abstract: OBJECTIVE
  5α-reductases are a family of isozymes expressed in a wide host of tissues including the central nervous system (CNS) and play a pivotal role in male sexual differentiation, development and physiology.
  
  
  METHODS
  A comprehensive literature search from 1970 to 2011 was made through PubMed and the relevant information was summarized.
  
  
  RESULTS
  5α reductases convert testosterone, progesterone, deoxycorticosterone, aldosterone and corticosterone into their respective 5α-dihydro-derivatives, which serve as substrates for 3α-hydroxysteroid dehydrogenase enzymes. The latter transforms these 5α-reduced metabolites into a subclass of neuroactive steroid hormones with distinct physiological functions. The neuroactive steroid hormones modulate a multitude of functions in human physiology encompassing regulation of sexual differentiation, neuroprotection, memory enhancement, anxiety, sleep and stress, among others. In addition, 5α -reductase type 3 is also implicated in the N-glycosylation of proteins via formation of dolichol phosphate. The family of 5α-reductases was targeted for drug development to treat pathophysiological conditions, such as benign prostatic hyperplasia and androgenetic alopecia. While the clinical use of 5α-reductase inhibitors was well established, the scope and the magnitude of the adverse side effects of such drugs, especially on the CNS, is still unrecognized due to lack of knowledge of the various physiological functions of this family of enzymes, especially in the CNS.
  
  
  CONCLUSIONS
  There is an urgent need to better understand the function of 5α-reductases and the role of neuroactive steroids in human physiology in order to minimize the potential adverse side effects of inhibitors targeting 5α-reductases to treat benign prostatic hyperplasia and androgenic alopecia.
authors.affiliation: Department of Urology, Boston University School of Medicine, Boston, Massachusetts 02118, USA. atraish@bu.edu
authors.forename: Abdulmaged M
authors.initials: AM
authors.lastname: Traish
mesh_terms: D000505:Alopecia / Q000188:drug therapy; D000818:Animals; D002490:Central Nervous System / Q000502:physiology*; D042944:Cholestenone 5 alpha-Reductase / Q000037:antagonists & inhibitors / Q000172:deficiency / Q000502:physiology*; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007527:Isoenzymes / Q000502:physiology; D008297:Male; D008568:Memory / Q000502:physiology*; D051379:Mice; D018345:Mice, Knockout; D023421:Models, Animal; D011470:Prostatic Hyperplasia / Q000188:drug therapy; D012733:Sex Differentiation / Q000502:physiology*
chemical_list: D004791:Enzyme Inhibitors; D007527:Isoenzymes; D042944:Cholestenone 5 alpha-Reductase